ChiCTR2100043680 版本V1.0 版本创建时间2021/06/21 19:38:11 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100043680 

最近更新日期:

Date of Last Refreshed on:

2021-02-26 23:10:28 

注册时间:

Date of Registration:

2021-02-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

以虚拟现实为基础的干预技术对酒依赖患者心理渴求的影响

Public title:

The effect of virtual reality-based intervention technology on psychological craving of alcohol-dependent patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

以虚拟现实为基础的干预技术对酒依赖患者心理渴求的影响

Scientific title:

The effect of virtual reality-based intervention technology on psychological craving of alcohol-dependent patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李文慧 

研究负责人:

李文慧 

Applicant:

wenhui Li 

Study leader:

wenhui Li 

申请注册联系人电话:

Applicant telephone:

15903051882

研究负责人电话:

Study leader's
telephone:

15903051882

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

whl882@faxmail.com

研究负责人电子邮件:

Study leader's E-mail:

whl882@faxmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省新乡市建设路388号

研究负责人通讯地址:

河南省新乡市建设路388号

Applicant address:

388 Jianshe Road, Xinxiang City, Henan Province, China

Study leader's address:

388 Jianshe Road, Xinxiang City, Henan Province, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

新乡医学院第二附属医院

Applicant's institution:

The Second Affiliated Hospital of Xinxiang Medical College

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

XYEFYLL-(科研)-2021-06

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新乡医学院第二附属医院伦理委员会

Name of the ethic committee:

The Ethics Committee of the Second Affiliated Hospital of Xinxiang Medical College

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

赵明军

Contact Name of the ethic committee:

mingjun Zhao

伦理委员会联系地址:

河南省新乡市建设路388号

Contact Address of the ethic committee:

388 Jianshe Road, Xinxiang City, Henan Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新乡医学院第二附属医院

Primary sponsor:

The Second Affiliated Hospital of Xinxiang Medical College

研究实施负责(组长)单位地址:

河南省新乡市建设路388号

Primary sponsor's address:

388 Jianshe Road, Xinxiang City, Henan Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南

市(区县):

新乡

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡医学院第二附属医院

具体地址:

建设路388号

Institution
hospital:

The Second Affiliated Hospital of Xinxiang Medical College

Address:

388 Jianshe Road

经费或物资来源:

河南省精神心理疾病临床医学研究中心

Source(s) of funding:

Clinical Medical Research Center of Mental Disorders of Henan Province

研究疾病:

酒精使用障碍  

Target disease:

Alcohol use disorder

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

开发一套诱发酒精渴求的虚拟现实系统,对酒精使用障碍患者进行干预,了解该干预模式在降低渴求、预防复饮方面的疗效。  

Objectives of Study:

Develop a virtual reality system to intervene in patients with alcohol use disorders and understand the effectiveness of the intervention model in reducing cravings and preventing relapse.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄18~60 岁,受教育程度在小学及以上;(2)酒依赖戒断综合征评定量表评分小于或等于3 分;(3)自愿参加,签署知情同意书。

Inclusion criteria

(1) Aged 18 to 60, with primary school education or above;(2) The score of the alcohol-dependence withdrawal syndrome rating scale was less than or equal to 3 points;(3) Participate voluntarily and sign the informed consent.

排除标准:

(1)患有其他精神疾病;(2)既往有脑器质性疾病、有起搏器或严重健康问题史;(3)既往有癫痫发作史;(4)合并严重躯体疾病;(5)其他药物依赖(除尼古丁依赖外);(6)害怕密闭空间;(7)有妨碍观看虚拟现实环境的视觉问题;(8)在过去30天内参与任何其他与酒精相关的研究或试验;(9)在过去30天内自报使用可能影响情绪或对酒精的渴求任何处方药或非处方药。

Exclusion criteria:

(1) suffer from other mental illnesses;(2) previous history of organic brain disease, pacemaker, or serious health problems;(3) previous seizure history;(4) Complicated with severe physical diseases;(5) other drug dependence (except nicotine dependence);(6) Fear of confined Spaces;(7) Visual problems that interfere with viewing virtual reality environments;(8) Participated in any other alcohol-related studies or trials within the past 30 days;(9) Self-reported use within the past 30 days of any prescription or over-the-counter drugs that may affect mood or cravings for alcohol.

研究实施时间:

Study execute time:

From 2021-03-01 00:00:00 To 2024-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-01 00:00:00 To 2023-09-01 00:00:00

干预措施:

Interventions:

组别:

研究组3

样本量:

30

Group:

Study Group

Sample size:

干预措施:

虚拟现实技术

干预措施代码:

Intervention:

Virtual Reality Technology

Intervention code:

组别:

对照组

样本量:

30

Group:

Control Group

Sample size:

干预措施:

常规治疗

干预措施代码:

Intervention:

regular treatment

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南 

市(区县):

 

Country:

China

Province:

Henan

City:

单位(医院):

新乡医学院第二附属医院 

单位级别:

三级甲等 

Institution
hospital:

The Second Affiliated Hospital of Xinxiang Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

渴求

指标类型:

主要指标

Outcome:

thirst

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

量表

组织:

Sample Name:

scale

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

项目实施者采用掷硬币方法随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

The project implementers were randomly assigned by a coin toss method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2024.12

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2024.12

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-02-26 23:10:28